Evidence map›Paper›PMID 35658521›Full record

ArticleJournal of bacteriology2022

Eriel Martínez, Carlos J Orihuela, Javier Campos-Gomez

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bacteriology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eriel MartínezDepartment of Microbiology, The University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.
Carlos J OrihuelaDepartment of Microbiology, The University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.ORCID 0000-0002-8542-4069
Javier Campos-GomezCystic Fibrosis Research Center, The University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.
University of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
PspA binds necroptotic cells to cause disease and transmitR01AI156898 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ORIHUELA, CARLOS J · 2020 to 2024
$2.0M
Capsule protects intracellular pneumococci during vascular endothelial cell translocationR21AI148368 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ORIHUELA, CARLOS J · 2020 to 2021
$408k
HHS | National Institutes of Health (NIH) AI114800HHS | National Institutes of Health (NIH) AI148368HHS | National Institutes of Health (NIH) AI156898NIAID NIH HHS R01 AI114800NIAID NIH HHS R01 AI156898NIAID NIH HHS R21 AI148368NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

The oxylipin-dependent quorum-sensing system (ODS) of Pseudomonas aeruginosa relies on the production and sensing of two extracellular oxylipins, 10

Indexed as

Type II Secretion SystemsBacterial ProteinsOleic AcidOxylipinsPseudomonas aeruginosaBacterial ProteinsOleic AcidOxylipinsType II Secretion Systemsautoinduceroleic acidoxylipinPseudomonas aeruginosaquorum sensingtype 2 secretion system

Identifiers

PMID35658521
PMCPMC9295564
OpenAlexW4281666776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.